XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Research and development expenses (Note 10) $ 1,810 $ 1,532
Marketing expenses (Note 11) 139 415
General and administrative expenses (Note 12) 2,091 1,185
Total operating expenses 4,040 3,132
Operating loss 4,040 3,132
Other expense (Income) 53 (338)
Financing income, net (26) (98)
Loss for the year 4,067 2,696
Other comprehensive loss:    
Foreign currency translation adjustment 21 109
Comprehensive loss for the year $ 4,088 $ 2,805
Loss per share (Basic and Diluted) $ 0.26 $ 0.19
Weighted average number of common stock outstanding used in computing basic and diluted net loss per share 15,450,824 15,079,182